Tresmares Capital has taken a minority stake in Rioja Nature Pharma
Madrid – CFI is pleased to announce that it acted as exclusive financial advisor to Rioja Nature Pharma in its sale of a minority stake to Tresmares Capital through a sharecapital increase.
Rioja Nature Pharma is a leading dietary supplements manufacturer for third parties with expected revenues of >€40M in 2023.
Tresmares Capital is a pan-European growth-focused alternative investment firm operating in Spain, the United Kingdom and Portugal. Founded in 2020 and comprising a team of 50 investment professionals, the firm offers an extensive range of financing solutions to both high-growth SMEs and their private equity backers.
This transaction closed in November 2023.
Food & Beverage & Agribusiness
has sold minority stake to
Transaction details
Leading dietary supplement provider Rioja Nature Pharma has sold a minority stake to private equity fund Tresmares Capital
Our latest transactions
Software & IT Services
have sold
to
a portfolio company of
Transaction details
Technology field services and support provider Vista Technology Support has been acquired by TRG
Consumer Goods & Retail
has obtained fundraising from
Transaction details
High-end bicycle producer The Rider Firm has obtained fundraising from Santander
Software & IT Services
has raised growth capital from
Transaction details
Digital Pills, an Italian Data & AI consulting company, has sold a minority stake to Equiter, raising funds for its future growth
